Real World Evidence & Research

In this episode of Unscripted, AMCP’s Mitzi Wasik (SVP, Practice Strategy & Innovation & AMCP Foundation Executive Director) and Cate Lockhart (Chief Science Officer, AMCP & Executive Director, Biologics & Biosimilars Collective Intelligence Consortium (BBCIC)), discuss where fragmentation occurs across the health care system and why pharmacists, payers, providers, and pathologists all play a critical role in fixing it. https://www.amcp.org/about/amcp-leadership/leadership-team

In today’s complex health care landscape, data-driven insights are key to better decision-making. AMCP’s 2024 Access, Affordability, and Outcomes (AAO) report highlights how managed care strategies improve patient care and reduce costs. From employer-covered insurance to the benefits of 90-day medication supplies, the report offers actionable data on affordability, adherence, and savings. Explore the full report to see how AMCP supports better, more affordable care.

On November 12, more than 50 managed care professionals and various health care stakeholders gathered in Old Town Alexandria, Virginia to examine these barriers to adoption for RWE in managed care. The multi-day meeting, our latest Partnership Forum event hosted by the AMCP Research Institute, consisted of a series of workshops that challenged participants to examine opportunities and challenges posed by RWE use and identify ways to address these barriers to adoption through refining and applying a set of RWE standards geared toward payer decision-makers that we have developed over the past year.

Host Fred Goldstein invites Charles Makin, Global HEOR, RWE and Market Access Advisor to discuss their poster at AMCP Nexus 2023 on RWE adoption by US Payers.